STEPHANIE WEAVER: Open Payments
NPI 1538513080 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 25 payments from 13 companies in 2025. Trend: 2023 $1,414 · 2024 $1,124 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $212 |
| GENZYME CORPORATION | 6 | $150 |
| PFIZER INC. | 4 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Almirall LLC | 1 | $26 |
| Incyte Corporation | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $23 |
| Cipher Pharmaceuticals US LLC | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
Products named: DUPIXENT, Rhapsido, CIBINQO, Seysara, OPZELURA, TREMFYA, Otezla, Natroba.
Industry payments across NC — which companies pay providers there.
